Posted by Michael Wonder on 21 Nov 2023
Sandoz launches Hyrimoz (adalimumab) high concentration formulation in Europe, aiming to improve patient care
21 November 2023 - Hyrimoz HCF to launch progressively across Europe.
Sandoz today announces the launch of Hyrimoz (adalimumab) citrate free high concentration formulation (100 mg/mL) in Europe.
